首页 > 最新文献

BMJ Evidence-Based Medicine最新文献

英文 中文
Rapid reviews methods series: considerations and recommendations for evidence synthesis in rapid reviews. 快速审查方法系列:快速审查证据综合的考虑因素和建议。
IF 9 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-22 DOI: 10.1136/bmjebm-2023-112617
Valerie J King, Barbara Nussbaumer-Streit, Elizabeth Shaw, Declan Devane, Leila Kahwati, Meera Viswanathan, Gerald Gartlehner
{"title":"Rapid reviews methods series: considerations and recommendations for evidence synthesis in rapid reviews.","authors":"Valerie J King, Barbara Nussbaumer-Streit, Elizabeth Shaw, Declan Devane, Leila Kahwati, Meera Viswanathan, Gerald Gartlehner","doi":"10.1136/bmjebm-2023-112617","DOIUrl":"10.1136/bmjebm-2023-112617","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"419-422"},"PeriodicalIF":9.0,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11671917/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142557089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical effect and contributing factors of acupuncture for knee osteoarthritis: a systematic review and pairwise and exploratory network meta-analysis. 针灸治疗膝骨关节炎的临床效果和诱因:系统综述、配对和探索性网络荟萃分析。
IF 9 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-22 DOI: 10.1136/bmjebm-2023-112626
Chuan-Yang Liu, Yan-Shan Duan, Hang Zhou, Yu Wang, Jian-Feng Tu, Xue-Ying Bao, Jing-Wen Yang, Myeong Soo Lee, Li-Qiong Wang

Objectives: This study aims to evaluate (1) the effect and safety of acupuncture in patients with knee osteoarthritis (KOA) and explore (2) whether the effect of acupuncture differed according to acupuncture type, acupuncture dose and follow-up time.

Design: Systematic review and pairwise and exploratory network meta-analysis.

Setting: PubMed, Embase, Cochrane Central Register of Controlled Trials, Web of Science, China National Knowledge Infrastructure, Chinese Biomedical Literature Database, VIP Database for Chinese Technical Periodicals and Wanfang from inception to 13 November 2023.

Participants: Randomised controlled trials comparing acupuncture with sham acupuncture, non-steroidal anti-inflammatory drugs (NSAIDs), usual care or waiting list groups, intra-articular (IA) injection and blank groups in patients with KOA.

Interventions: Eligible interventions included manual acupuncture (MA) and electroacupuncture (EA).

Main outcomes measures: The primary outcome was pain intensity at the end of treatment.

Results: 80 trials (9933 participants) were included. Very low certainty evidence suggested that acupuncture may reduce pain intensity compared with sham acupuncture (standardised mean difference, SMD -0.74, 95% CI -1.08 to -0.39, corresponded to a difference in Visual Analogue Scale of -18.50 mm, -27.00 to -9.75), NSAIDs (SMD -0.86 -1.26 to -0.46, corresponded to -21.50 mm, -31.50 to -11.50), usual care or waiting list groups (SMD -1.01, -1.47 to -0.54, corresponded to -25.25 mm, -36.75 to -13.50) and blank groups (SMD -1.65, -1.99 to -1.32, corresponded to -41.25 mm, -49.75 to -33.00), but not IA injection. Similar results were also found in other outcomes. For most of the subgroup analyses, acupuncture type, acupuncture dose and follow-up time did not show a significant relative effect. Only when compared with NSAIDs, a higher dose of acupuncture may provide greater pain relief (interaction p<0.001). The network meta-analysis revealed that electroacupuncture (SMD -0.75, 95% CI -1.34 to -0.17) had a greater effect on pain relief in patients with KOA compared with manual acupuncture.

Conclusions: The findings suggest that acupuncture may provide clinically important effects in reducing pain and improving physical function in patients with KOA, but the certainty of evidence was very low. Electroacupuncture and higher dose of acupuncture probably are two potential contributing factors.

Prospero registration number: CRD42021232177.

研究目的本研究旨在评估(1)针灸对膝关节骨性关节炎(KOA)患者的效果和安全性,并探讨(2)针灸效果是否因针灸类型、针灸剂量和随访时间而有所不同:设计:系统回顾、配对和探索性网络荟萃分析:PubMed、Embase、Cochrane对照试验中央注册中心、Web of Science、中国国家知识基础设施、中国生物医学文献数据库、中国科技期刊VIP数据库和万方数据库(从开始到2023年11月13日):在KOA患者中比较针灸与假针灸、非甾体类抗炎药(NSAIDs)、常规护理或候诊组、关节内注射(IA)和空白组的随机对照试验:符合条件的干预措施包括人工针灸(MA)和电针(EA):主要结果测量:主要结果是治疗结束时的疼痛强度:结果:共纳入 80 项试验(9933 名参与者)。确定性极低的证据表明,与假针灸相比,针灸可降低疼痛强度(标准化平均差,SMD -0.74,95% CI -1.08 至 -0.39,相当于视觉模拟量表的差异为 -18.50 mm,-27.00 至 -9.75),与非甾体抗炎药相比,针灸可降低疼痛强度(SMD -0.86至 -1.26至-0.46,相当于-21.50毫米,-31.50至-11.50)、常规护理或等待名单组(SMD-1.01,-1.47至-0.54,相当于-25.25毫米,-36.75至-13.50)和空白组(SMD-1.65,-1.99至-1.32,相当于-41.25毫米,-49.75至-33.00),但不包括IA注射。其他结果也有类似结果。在大多数亚组分析中,针灸类型、针灸剂量和随访时间都没有显示出显著的相对效应。只有与非甾体抗炎药相比,针灸剂量越大,疼痛缓解效果越好(交互作用 p 结论:研究结果表明,针灸在减轻 KOA 患者疼痛和改善身体功能方面可能具有重要的临床效果,但证据的确定性很低。电针和较高的针灸剂量可能是两个潜在的促成因素:CRD42021232177。
{"title":"Clinical effect and contributing factors of acupuncture for knee osteoarthritis: a systematic review and pairwise and exploratory network meta-analysis.","authors":"Chuan-Yang Liu, Yan-Shan Duan, Hang Zhou, Yu Wang, Jian-Feng Tu, Xue-Ying Bao, Jing-Wen Yang, Myeong Soo Lee, Li-Qiong Wang","doi":"10.1136/bmjebm-2023-112626","DOIUrl":"10.1136/bmjebm-2023-112626","url":null,"abstract":"<p><strong>Objectives: </strong>This study aims to evaluate (1) the effect and safety of acupuncture in patients with knee osteoarthritis (KOA) and explore (2) whether the effect of acupuncture differed according to acupuncture type, acupuncture dose and follow-up time.</p><p><strong>Design: </strong>Systematic review and pairwise and exploratory network meta-analysis.</p><p><strong>Setting: </strong>PubMed, Embase, Cochrane Central Register of Controlled Trials, Web of Science, China National Knowledge Infrastructure, Chinese Biomedical Literature Database, VIP Database for Chinese Technical Periodicals and Wanfang from inception to 13 November 2023.</p><p><strong>Participants: </strong>Randomised controlled trials comparing acupuncture with sham acupuncture, non-steroidal anti-inflammatory drugs (NSAIDs), usual care or waiting list groups, intra-articular (IA) injection and blank groups in patients with KOA.</p><p><strong>Interventions: </strong>Eligible interventions included manual acupuncture (MA) and electroacupuncture (EA).</p><p><strong>Main outcomes measures: </strong>The primary outcome was pain intensity at the end of treatment.</p><p><strong>Results: </strong>80 trials (9933 participants) were included. Very low certainty evidence suggested that acupuncture may reduce pain intensity compared with sham acupuncture (standardised mean difference, SMD -0.74, 95% CI -1.08 to -0.39, corresponded to a difference in Visual Analogue Scale of -18.50 mm, -27.00 to -9.75), NSAIDs (SMD -0.86 -1.26 to -0.46, corresponded to -21.50 mm, -31.50 to -11.50), usual care or waiting list groups (SMD -1.01, -1.47 to -0.54, corresponded to -25.25 mm, -36.75 to -13.50) and blank groups (SMD -1.65, -1.99 to -1.32, corresponded to -41.25 mm, -49.75 to -33.00), but not IA injection. Similar results were also found in other outcomes. For most of the subgroup analyses, acupuncture type, acupuncture dose and follow-up time did not show a significant relative effect. Only when compared with NSAIDs, a higher dose of acupuncture may provide greater pain relief (interaction p<0.001). The network meta-analysis revealed that electroacupuncture (SMD -0.75, 95% CI -1.34 to -0.17) had a greater effect on pain relief in patients with KOA compared with manual acupuncture.</p><p><strong>Conclusions: </strong>The findings suggest that acupuncture may provide clinically important effects in reducing pain and improving physical function in patients with KOA, but the certainty of evidence was very low. Electroacupuncture and higher dose of acupuncture probably are two potential contributing factors.</p><p><strong>Prospero registration number: </strong>CRD42021232177.</p>","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"374-384"},"PeriodicalIF":9.0,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11672105/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142563943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quantifying the time-varying association between objectively measured physical activity and mortality in US older adults over a 12-year follow-up period: the NHANES 2003-2006 study. 量化美国老年人在 12 年随访期内客观测量的体力活动与死亡率之间的时变关系:NHANES 2003-2006 年研究。
IF 9 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-22 DOI: 10.1136/bmjebm-2023-112303
Neha Agarwala, Vadim Zipunnikov, Ciprian Crainiceanu, Andrew Leroux

Objectively measuring physical activity (PA) has consistently shown an association with reduced all-cause mortality risk in cross-sectional studies. However, the strength of this association may change over time. We quantify the time-varying, covariate-adjusted association between the total volume of PA and all-cause mortality over a 12-year follow-up period using Cox regression with a time varying effect of population-referenced quantile total activity count adjusted for traditional risk factors. Analyses focus on participants 50-84 years old with adequate accelerometer wear time and without missing covariates. The findings suggest that (1) the use of baseline PA in Cox models with long follow-up periods may be inappropriate without time-varying effects and (2) the use of accelerometry derived volume of PA in risk score calculations may be most appropriate for short-term to medium-term risk scores.

在横断面研究中,对体力活动(PA)进行客观测量的结果显示,体力活动与降低全因死亡风险有关联。然而,这种关联的强度可能会随着时间的推移而改变。我们采用 Cox 回归方法量化了随时间变化的、经协变量调整的体育锻炼总量与 12 年随访期内全因死亡率之间的关系,并对传统风险因素进行了调整。分析主要针对年龄在 50-84 岁、有足够加速度计佩戴时间且没有缺失协变量的参与者。研究结果表明:(1) 在没有时变效应的情况下,在长时间随访的 Cox 模型中使用基线活动量可能并不合适;(2) 在计算风险评分时使用加速度计得出的活动量可能最适合短期到中期的风险评分。
{"title":"Quantifying the time-varying association between objectively measured physical activity and mortality in US older adults over a 12-year follow-up period: the NHANES 2003-2006 study.","authors":"Neha Agarwala, Vadim Zipunnikov, Ciprian Crainiceanu, Andrew Leroux","doi":"10.1136/bmjebm-2023-112303","DOIUrl":"10.1136/bmjebm-2023-112303","url":null,"abstract":"<p><p>Objectively measuring physical activity (PA) has consistently shown an association with reduced all-cause mortality risk in cross-sectional studies. However, the strength of this association may change over time. We quantify the time-varying, covariate-adjusted association between the total volume of PA and all-cause mortality over a 12-year follow-up period using Cox regression with a time varying effect of population-referenced quantile total activity count adjusted for traditional risk factors. Analyses focus on participants 50-84 years old with adequate accelerometer wear time and without missing covariates. The findings suggest that (1) the use of baseline PA in Cox models with long follow-up periods may be inappropriate without time-varying effects and (2) the use of accelerometry derived volume of PA in risk score calculations may be most appropriate for short-term to medium-term risk scores.</p>","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"409-414"},"PeriodicalIF":9.0,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11390972/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140109060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CARE-radiology statement explanation and elaboration: reporting guideline for radiological case reports. CARE-radiology statement explanation and elaboration:放射病例报告指南。
IF 9 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-22 DOI: 10.1136/bmjebm-2023-112695
Mengshu Wang, Xufei Luo, Xiaojuan Xiao, Linlin Zhang, Qi Wang, Shiyu Wang, Ximing Wang, Huadan Xue, Longjiang Zhang, Yaolong Chen, Junqiang Lei, Tomaž Štupnik, Marco Scarci, Alfonso Fiorelli, Tanel Laisaar, Robert Fruscio, Hussein Elkhayat, Nuria M Novoa, Fabio Davoli, Ryuichi Waseda, Janne Estill, Susan L Norris, David S Riley, Jinhui Tian

Despite the increasing number of radiological case reports, the majority lack a standardised methodology of writing and reporting. We therefore develop a reporting guideline for radiological case reports based on the CAse REport (CARE) statement. We established a multidisciplinary group of experts, comprising 40 radiologists, methodologists, journal editors and researchers, to develop a reporting guideline for radiological case reports according to the methodology recommended by the Enhancing the QUAlity and Transparency Of health Research network. The Delphi panel was requested to evaluate the significance of a list of elements for potential inclusion in a guideline for reporting mediation analyses. By reviewing the reporting guidelines and through discussion, we initially drafted 46 potential items. Following a Delphi survey and discussion, the final CARE-radiology checklist is comprised of 38 items in 16 domains. CARE-radiology is a comprehensive reporting guideline for radiological case reports developed using a rigorous methodology. We hope that compliance with CARE-radiology will help in the future to improve the completeness and quality of case reports in radiology.

尽管放射病例报告的数量不断增加,但大多数报告都缺乏标准化的撰写和报告方法。因此,我们根据 "病例报告"(CARE)声明制定了放射病例报告指南。我们成立了一个多学科专家小组,由 40 名放射科医生、方法论专家、期刊编辑和研究人员组成,按照 "提高健康研究的质量和透明度 "网络推荐的方法制定放射病例报告的报告指南。德尔菲小组被要求评估可能纳入中介分析报告指南的一系列要素的重要性。通过审查报告指南和讨论,我们初步起草了 46 个潜在项目。经过德尔菲调查和讨论,最终的 CARE-radiology 核对表由 16 个领域的 38 个项目组成。CARE-radiology 是采用严格方法制定的放射病例报告综合报告指南。我们希望遵守 CARE-radiology 将有助于提高放射学病例报告的完整性和质量。
{"title":"CARE-radiology statement explanation and elaboration: reporting guideline for radiological case reports.","authors":"Mengshu Wang, Xufei Luo, Xiaojuan Xiao, Linlin Zhang, Qi Wang, Shiyu Wang, Ximing Wang, Huadan Xue, Longjiang Zhang, Yaolong Chen, Junqiang Lei, Tomaž Štupnik, Marco Scarci, Alfonso Fiorelli, Tanel Laisaar, Robert Fruscio, Hussein Elkhayat, Nuria M Novoa, Fabio Davoli, Ryuichi Waseda, Janne Estill, Susan L Norris, David S Riley, Jinhui Tian","doi":"10.1136/bmjebm-2023-112695","DOIUrl":"10.1136/bmjebm-2023-112695","url":null,"abstract":"<p><p>Despite the increasing number of radiological case reports, the majority lack a standardised methodology of writing and reporting. We therefore develop a reporting guideline for radiological case reports based on the CAse REport (CARE) statement. We established a multidisciplinary group of experts, comprising 40 radiologists, methodologists, journal editors and researchers, to develop a reporting guideline for radiological case reports according to the methodology recommended by the Enhancing the QUAlity and Transparency Of health Research network. The Delphi panel was requested to evaluate the significance of a list of elements for potential inclusion in a guideline for reporting mediation analyses. By reviewing the reporting guidelines and through discussion, we initially drafted 46 potential items. Following a Delphi survey and discussion, the final CARE-radiology checklist is comprised of 38 items in 16 domains. CARE-radiology is a comprehensive reporting guideline for radiological case reports developed using a rigorous methodology. We hope that compliance with CARE-radiology will help in the future to improve the completeness and quality of case reports in radiology.</p>","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"399-408"},"PeriodicalIF":9.0,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11672047/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140064785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
iHealthFacts: a health fact-checking website for the public. iHealthFacts: 面向公众的健康事实核查网站。
IF 9 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-22 DOI: 10.1136/bmjebm-2023-112611
Paula Byrne, Anne Daly, Deirdre Mac Loughlin, Caoimhe Madden, Therese Mc Donnell, Claire O'Connell, Johanna Pope, K M Saif-Ur-Rahman, Petek Eylul Taneri, Marie Tierney, Elaine Toomey, Declan Devane
{"title":"iHealthFacts: a health fact-checking website for the public.","authors":"Paula Byrne, Anne Daly, Deirdre Mac Loughlin, Caoimhe Madden, Therese Mc Donnell, Claire O'Connell, Johanna Pope, K M Saif-Ur-Rahman, Petek Eylul Taneri, Marie Tierney, Elaine Toomey, Declan Devane","doi":"10.1136/bmjebm-2023-112611","DOIUrl":"10.1136/bmjebm-2023-112611","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"415-418"},"PeriodicalIF":9.0,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141320532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Guidelines for the development and validation of patient-reported outcome measures: a scoping review. 患者报告结果测量的开发和验证指南:范围审查。
IF 9 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-22 DOI: 10.1136/bmjebm-2023-112681
Andres Jung, Dimitris Challoumas, Larissa Pagels, Susan Armijo-Olivo, Tobias Braun, Kerstin Luedtke

Objective: The objectives of this scoping review were to provide an overview of existing guidelines for the development and validation of patient-reported outcome measures (PROMs), review them for comprehensiveness and clarity and provide recommendations for their use based on the goals of the instrument developers.

Design: Scoping review.

Methods: A literature search was performed in PubMed, Scopus, PsycInfo and Google Scholar up to 2 June 2023 to identify guidelines for the development and validation of PROMs. Screening of records and reports as well as data extraction were performed by two reviewers. To assess the comprehensiveness of the included guidelines, a mapping synthesis was performed and steps to develop and validate a measurement instrument outlined in the included guidelines were mapped to an a priori framework including 20 steps, which was based on the guideline by de Vet et al.

Results: A total of 40 guidelines were included. Statistical advice (at least partially) was provided in 98% of the guidelines (39/40) and 88% (35/40) of the guidelines included examples for steps required to develop and validate PROMs. However, 78% (31/40) of the guidelines were not comprehensive and two essential steps in PROM development ('consideration and elaboration of the measurement model' and 'responsiveness') were not included in 80% and 72% of the guidelines, respectively. Three guidelines included all 20 steps and six included almost all steps (≥90% of steps) for developing and validating a PROM.

Discussion: Most guidelines on PROM development and validation do not appear to be comprehensive, and some crucial steps are missing in most guidelines. Nevertheless, for some purposes of PROMs, many guidelines provide helpful advice and support.

Conclusion: At least 15 guidelines may be recommended, including three comprehensive guidelines that can be recommended for the development and validation of PROMs for most purposes (eg, to discriminate between subjects with a particular condition and subjects without that condition, to evaluate the effects of treatments (between a pre and post time-points) or to evaluate a status quo).

目的:本范围综述旨在概述现有的患者报告结果测量(PROMs)开发和验证指南,审查其全面性和清晰性,并根据工具开发者的目标为其使用提供建议:范围综述:方法:在 PubMed、Scopus、PsycInfo 和 Google Scholar 中进行文献检索,时间截至 2023 年 6 月 2 日,以确定 PROMs 的开发和验证指南。记录和报告的筛选以及数据提取由两名审稿人完成。为了评估所收录指南的全面性,我们进行了映射综合,并将所收录指南中列出的开发和验证测量工具的步骤映射到一个先验框架中,该框架包括20个步骤,是以de Vet等人的指南为基础的:结果:共纳入 40 项指南。98%的指南(39/40)提供了统计建议(至少部分),88%的指南(35/40)包含了开发和验证 PROM 所需的步骤示例。然而,78%(31/40)的指南并不全面,分别有 80% 和 72% 的指南没有包含 PROM 开发中的两个基本步骤("考虑和阐述测量模型 "和 "响应性")。三份指南包含了开发和验证 PROM 的全部 20 个步骤,六份指南几乎包含了所有步骤(≥ 90% 的步骤):讨论:大多数关于 PROM 开发和验证的指南似乎并不全面,而且大多数指南都缺少一些关键步骤。尽管如此,对于某些目的的 PROM,许多指南还是提供了有益的建议和支持:结论:至少有 15 项指南可以推荐使用,其中有 3 项综合指南可以推荐用于开发和验证 PROMs,以满足大多数目的(例如,区分患有特定疾病的受试者和未患有该疾病的受试者、评估治疗效果(前后时间点之间)或评估现状)。
{"title":"Guidelines for the development and validation of patient-reported outcome measures: a scoping review.","authors":"Andres Jung, Dimitris Challoumas, Larissa Pagels, Susan Armijo-Olivo, Tobias Braun, Kerstin Luedtke","doi":"10.1136/bmjebm-2023-112681","DOIUrl":"10.1136/bmjebm-2023-112681","url":null,"abstract":"<p><strong>Objective: </strong>The objectives of this scoping review were to provide an overview of existing guidelines for the development and validation of patient-reported outcome measures (PROMs), review them for comprehensiveness and clarity and provide recommendations for their use based on the goals of the instrument developers.</p><p><strong>Design: </strong>Scoping review.</p><p><strong>Methods: </strong>A literature search was performed in PubMed, Scopus, PsycInfo and Google Scholar up to 2 June 2023 to identify guidelines for the development and validation of PROMs. Screening of records and reports as well as data extraction were performed by two reviewers. To assess the comprehensiveness of the included guidelines, a mapping synthesis was performed and steps to develop and validate a measurement instrument outlined in the included guidelines were mapped to an a priori framework including 20 steps, which was based on the guideline by de Vet <i>et al</i>.</p><p><strong>Results: </strong>A total of 40 guidelines were included. Statistical advice (at least partially) was provided in 98% of the guidelines (39/40) and 88% (35/40) of the guidelines included examples for steps required to develop and validate PROMs. However, 78% (31/40) of the guidelines were not comprehensive and two essential steps in PROM development ('consideration and elaboration of the measurement model' and 'responsiveness') were not included in 80% and 72% of the guidelines, respectively. Three guidelines included all 20 steps and six included almost all steps (≥90% of steps) for developing and validating a PROM.</p><p><strong>Discussion: </strong>Most guidelines on PROM development and validation do not appear to be comprehensive, and some crucial steps are missing in most guidelines. Nevertheless, for some purposes of PROMs, many guidelines provide helpful advice and support.</p><p><strong>Conclusion: </strong>At least 15 guidelines may be recommended, including three comprehensive guidelines that can be recommended for the development and validation of PROMs for most purposes (eg, to discriminate between subjects with a particular condition and subjects without that condition, to evaluate the effects of treatments (between a pre and post time-points) or to evaluate a status quo).</p>","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"363-373"},"PeriodicalIF":9.0,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141086867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overcoming challenges in the implementation of clinical practice guidelines in China. 克服在中国实施临床实践指南的挑战。
IF 9 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-18 DOI: 10.1136/bmjebm-2024-112896
Dongmei Zhong, Nan Yang, Yaolong Chen, Dong Roman Xu
{"title":"Overcoming challenges in the implementation of clinical practice guidelines in China.","authors":"Dongmei Zhong, Nan Yang, Yaolong Chen, Dong Roman Xu","doi":"10.1136/bmjebm-2024-112896","DOIUrl":"https://doi.org/10.1136/bmjebm-2024-112896","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":""},"PeriodicalIF":9.0,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142457702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing clinical practice guidelines with STAR. 利用 STAR 加强临床实践指南。
IF 9 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-09 DOI: 10.1136/bmjebm-2024-112893
Nan Yang, Hui Liu, Janne Estill, Yaolong Chen
{"title":"Enhancing clinical practice guidelines with STAR.","authors":"Nan Yang, Hui Liu, Janne Estill, Yaolong Chen","doi":"10.1136/bmjebm-2024-112893","DOIUrl":"https://doi.org/10.1136/bmjebm-2024-112893","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":""},"PeriodicalIF":9.0,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142387837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meet generative AI… your new shared decision-making assistant. 认识一下生成式人工智能......您新的共同决策助手。
IF 9 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-20 DOI: 10.1136/bmjebm-2023-112651
Glyn Elwyn, Padhraig Ryan, Daniel Blumkin, William B Weeks
{"title":"Meet generative AI… your new shared decision-making assistant.","authors":"Glyn Elwyn, Padhraig Ryan, Daniel Blumkin, William B Weeks","doi":"10.1136/bmjebm-2023-112651","DOIUrl":"10.1136/bmjebm-2023-112651","url":null,"abstract":"","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"292-295"},"PeriodicalIF":9.0,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141309953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinician and health service interventions to reduce the greenhouse gas emissions generated by healthcare: a systematic review. 减少医疗保健产生的温室气体排放的临床医生和医疗服务干预措施:系统综述。
IF 9 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-20 DOI: 10.1136/bmjebm-2023-112707
Kristen Pickles, Romi Haas, Michelle Guppy, Denise A O'Connor, Thanya Pathirana, Alexandra Barratt, Rachelle Buchbinder
<p><strong>Objective: </strong>To synthesise the available evidence on the effects of interventions designed to improve the delivery of healthcare that reduces the greenhouse gas (GHG) emissions of healthcare.</p><p><strong>Design: </strong>Systematic review and structured synthesis.</p><p><strong>Search sources: </strong>Cochrane Central Register of Controlled Trials, PubMed, Web of Science and Embase from inception to 3 May 2023.</p><p><strong>Selection criteria: </strong>Randomised, quasi-randomised and non-randomised controlled trials, interrupted time series and controlled or uncontrolled before-after studies that assessed interventions primarily designed to improve the delivery of healthcare that reduces the GHG emissions of healthcare initiated by clinicians or healthcare services within any setting.</p><p><strong>Main outcome measures: </strong>Primary outcome was GHG emissions. Secondary outcomes were financial costs, effectiveness, harms, patient-relevant outcomes, engagement and acceptability.</p><p><strong>Data collection and analysis: </strong>Paired authors independently selected studies for inclusion, extracted data, and assessed risk of bias using a modified checklist for observational studies and the certainty of the evidence using Grades of Recommendation, Assessment, Development and Evaluation. Data could not be pooled because of clinical and methodological heterogeneity, so we synthesised results in a structured summary of intervention effects with vote counting based on direction of effect.</p><p><strong>Results: </strong>21 observational studies were included. Interventions targeted delivery of anaesthesia (12 of 21), waste/recycling (5 of 21), unnecessary test requests (3 of 21) and energy (1 of 21). The primary intervention type was clinician education. Most (20 of 21) studies were judged at unclear or high risk of bias for at least one criterion. Most studies reported effect estimates favouring the intervention (GHG emissions 17 of 18, costs 13 of 15, effectiveness 18 of 20, harms 1 of 1 and staff acceptability 1 of 1 studies), but the evidence is very uncertain for all outcomes (downgraded predominantly for observational study design and risk of bias). No studies reported patient-relevant outcomes other than death or engagement with the intervention.</p><p><strong>Conclusions: </strong>Interventions designed to improve the delivery of healthcare that reduces GHG emissions may reduce GHG emissions and costs, reduce anaesthesia use, waste and unnecessary testing, be acceptable to staff and have little to no effect on energy use or unintended harms, but the evidence is very uncertain. Rigorous studies that measure GHG emissions using gold-standard life cycle assessment are needed as well as studies in more diverse areas of healthcare. It is also important that future interventions to reduce GHG emissions evaluate the effect on beneficial and harmful patient outcomes.</p><p><strong>Prospero registration number: </strong>CRD4
目的综述旨在改善医疗服务、减少医疗服务温室气体(GHG)排放的干预措施效果的现有证据:设计:系统回顾和结构化综合:检索来源:Cochrane Central Register of Controlled Trials、PubMed、Web of Science 和 Embase(从开始到 2023 年 5 月 3 日):随机、准随机和非随机对照试验、间断时间序列和对照或非对照的前后研究,这些研究评估了由临床医生或医疗保健服务机构在任何环境下发起的主要旨在改善医疗保健服务、减少医疗保健温室气体排放的干预措施:主要结果测量指标:主要结果为温室气体排放量。次要结果为财务成本、有效性、危害、患者相关结果、参与度和可接受性:配对作者独立选择纳入研究、提取数据,并使用观察性研究的修改检查表评估偏倚风险,以及使用推荐、评估、开发和评价等级评估证据的确定性。由于临床和方法上的异质性,无法对数据进行汇总,因此我们以结构化的干预效果总结的形式对结果进行了综合,并根据效果的方向进行了计票。干预措施针对麻醉的实施(21 项中的 12 项)、废物/回收(21 项中的 5 项)、不必要的检查请求(21 项中的 3 项)和能源(21 项中的 1 项)。主要干预类型是临床医生教育。大多数研究(21 项中的 20 项)至少有一项标准被判定为偏倚风险不明确或偏倚风险较高。大多数研究报告的效果估计值倾向于干预(18 项研究中有 17 项报告了温室气体排放,15 项研究中有 13 项报告了成本,20 项研究中有 18 项报告了效果,1 项研究中有 1 项报告了危害,1 项研究中有 1 项报告了员工接受度),但所有结果的证据都非常不确定(主要因观察性研究设计和偏倚风险而降级)。除死亡或参与干预外,没有其他研究报告了与患者相关的结果:旨在改善医疗服务、减少温室气体排放的干预措施可能会减少温室气体排放和成本,减少麻醉使用、浪费和不必要的检查,为员工所接受,并且对能源使用或意外伤害几乎没有影响,但证据非常不确定。需要进行严格的研究,使用黄金标准的生命周期评估来测量温室气体排放量,并在更多的医疗保健领域进行研究。同样重要的是,未来减少温室气体排放的干预措施应评估对患者有益和有害结果的影响:CRD42022309428。
{"title":"Clinician and health service interventions to reduce the greenhouse gas emissions generated by healthcare: a systematic review.","authors":"Kristen Pickles, Romi Haas, Michelle Guppy, Denise A O'Connor, Thanya Pathirana, Alexandra Barratt, Rachelle Buchbinder","doi":"10.1136/bmjebm-2023-112707","DOIUrl":"10.1136/bmjebm-2023-112707","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To synthesise the available evidence on the effects of interventions designed to improve the delivery of healthcare that reduces the greenhouse gas (GHG) emissions of healthcare.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design: &lt;/strong&gt;Systematic review and structured synthesis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Search sources: &lt;/strong&gt;Cochrane Central Register of Controlled Trials, PubMed, Web of Science and Embase from inception to 3 May 2023.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Selection criteria: &lt;/strong&gt;Randomised, quasi-randomised and non-randomised controlled trials, interrupted time series and controlled or uncontrolled before-after studies that assessed interventions primarily designed to improve the delivery of healthcare that reduces the GHG emissions of healthcare initiated by clinicians or healthcare services within any setting.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main outcome measures: &lt;/strong&gt;Primary outcome was GHG emissions. Secondary outcomes were financial costs, effectiveness, harms, patient-relevant outcomes, engagement and acceptability.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Data collection and analysis: &lt;/strong&gt;Paired authors independently selected studies for inclusion, extracted data, and assessed risk of bias using a modified checklist for observational studies and the certainty of the evidence using Grades of Recommendation, Assessment, Development and Evaluation. Data could not be pooled because of clinical and methodological heterogeneity, so we synthesised results in a structured summary of intervention effects with vote counting based on direction of effect.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;21 observational studies were included. Interventions targeted delivery of anaesthesia (12 of 21), waste/recycling (5 of 21), unnecessary test requests (3 of 21) and energy (1 of 21). The primary intervention type was clinician education. Most (20 of 21) studies were judged at unclear or high risk of bias for at least one criterion. Most studies reported effect estimates favouring the intervention (GHG emissions 17 of 18, costs 13 of 15, effectiveness 18 of 20, harms 1 of 1 and staff acceptability 1 of 1 studies), but the evidence is very uncertain for all outcomes (downgraded predominantly for observational study design and risk of bias). No studies reported patient-relevant outcomes other than death or engagement with the intervention.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Interventions designed to improve the delivery of healthcare that reduces GHG emissions may reduce GHG emissions and costs, reduce anaesthesia use, waste and unnecessary testing, be acceptable to staff and have little to no effect on energy use or unintended harms, but the evidence is very uncertain. Rigorous studies that measure GHG emissions using gold-standard life cycle assessment are needed as well as studies in more diverse areas of healthcare. It is also important that future interventions to reduce GHG emissions evaluate the effect on beneficial and harmful patient outcomes.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Prospero registration number: &lt;/strong&gt;CRD4","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"300-312"},"PeriodicalIF":9.0,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11503105/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141086863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
BMJ Evidence-Based Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1